Robert A. Hamilton, Pharm.D., MPH

Bio: 

Education

Pharm.D., Medical College of Virginia
B.S., Albany College of Pharmacy and Health Sciences

Courses Taught at ACPHS

Seminar Clerkship in Pharmacotherapy

Research Interests

Pharmacoepidemiology, especially as it relates to the application of treatment guidelines to care and the development of adverse reactions to drugs or drug interactions.

Selected Publications

Triller D.M., Clause S.L., Hamilton RA, Risk of adverse drug events by patient destination after hospital discharge. Am J Health-Syst Pharm. 2005; 62:1883-1889. 

Clause SL, Triller DM, Bornhorst CPH, Hamilton RA and Cosler LE. Conforming to HIPAA regulations and compilation of research data. Am J Health-Syst Pharm2004;61:1025-31.

Stroup J, Kane MP, Busch RS, Bakst G and Hamilton RA. The utility of insulin glargine in the treatment of diabetes mellitus. Pharmacotherapy 2004;24:736-42.

Kane MP, Busch RS, Bakst G and Hamilton RA. Substitution of pioglitazone for troglitazone in patients with type 2 diabetes. Endocrine Practice 2004;10:18-23.

Professor
Assistant Dean, VT Campus
Department of Pharmacy Practice